Article Information
History
- July 27, 2021.
Article Versions
- Version 1 (May 27, 2021 - 08:31).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Noa Furth1,¶,
- Shay Shilo1,¶,
- Niv Cohen1,¶,
- Nir Erez1,
- Vadim Fedyuk1,
- Alexander M. Schrager2,
- Adina Weinberger3,
- Amiel A. Dror4,7,
- Asaf Zigron5,7,
- Mona Shehadeh6,7,
- Eyal Sela4,7,
- Samer Srouji5,7,
- Sharon Amit8,
- Itzchak Levy8,9,
- Eran Segal3,
- Rony Dahan10,
- Dan Jones11,
- Daniel C. Douek2 and
- Efrat Shema1,*
- 1Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel
- 2Human Immunology Section, Vaccine Research Center, National Institutes of Health, Bethesda, MD, USA
- 3Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
- 4Department of Otolaryngology, Head and Neck Surgery, Galilee Medical Center, Nahariya, Israel
- 5Oral and Maxillofacial Department, Galilee Medical Center, Nahariya, Israel
- 6Clinical Laboratories division, Clinical Biochemistry and Endocrinology laboratory, Galilee Medical Center, Naharia, Israel
- 7The Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel
- 8Sheba Medical Center, Ramat Gan, Israel
- 9Sackler Medical School, Tel Aviv university, Tel Aviv, Israel
- 10Department of Immunology, Weizmann Institute of Science, Rehovot, Israel
- 11SeqLL, Woburn, MA, USA
- ↵*Corresponding author: Efrat.shema{at}weizmann.ac.il
↵¶ These authors contributed equally to this work
Posted July 27, 2021.
Unified platform for genetic and serological detection of COVID-19 with single-molecule technology
